Merck
CN
所有图片(1)

文件

安全信息

C-130

Supelco

可的松标准液 溶液

100 μg/mL in methanol, ampule of 1 mL, certified reference material, Cerilliant®

登录查看公司和协议定价
所有图片(1)
经验公式（希尔记法）:
C21H28O5
CAS号:
53-06-5
分子量:
360.44
EC 号:
200-659-6
NACRES:
NA.24

等级

certified reference material

形式

liquid

特点

(Snap-N-Spike®)

包装

ampule of 1 mL

manufacturer/tradename

Cerilliant®

浓度

100 μg/mL in methanol

technique(s)

gas chromatography (GC): suitable
liquid chromatography (LC): suitable

application(s)

clinical testing
clinical testing

格式

single component solution

储存温度

−20°C

InChI

1S/C21H28O5/c1-19-7-5-13(23)9-12(19)3-4-14-15-6-8-21(26,17(25)11-22)20(15,2)10-16(24)18(14)19/h9,14-15,18,22,26H,3-8,10-11H2,1-2H3/t14-,15-,18+,19-,20-,21-/m0/s1

InChI key

MFYSYFVPBJMHGN-ZPOLXVRWSA-N

相关类别

一般描述

可的松是在肾上腺中产生的一种皮质类固醇。 使用可的松能够在短期内缓解疼痛并减少炎症引起的肿胀。此认证加标溶液®适用于内分泌，临床化学和新生儿筛查LC-MS/MS应用。

法律信息

CERILLIANT is a registered trademark of Merck KGaA, Darmstadt, Germany
CERTIFIED SPIKING SOLUTION is a registered trademark of Cerilliant Corporation
Snap-N-Spike is a registered trademark of Merck KGaA, Darmstadt, Germany

相关产品

产品编号
说明
价格

A-096

醛固酮标准液 溶液, 100 μg/mL in acetonitrile, ampule of 1 mL, certified reference material, Cerilliant®

C-106

皮质醇标准液 溶液, 1.0 mg/mL in methanol, ampule of 1 mL, certified reference material, Cerilliant®

C-113

氢化可的松-D4标准液 CRM 溶液, 100 μg/mL in methanol, ampule of 1 mL, certified reference material, Cerilliant®

C-117

皮质酮标准液 溶液, 1.0 mg/mL in methanol, ampule of 1 mL, certified reference material, Cerilliant®

D-061

11-脱氧皮质激素标准液 溶液, 1.0 mg/mL in methanol, ampule of 1 mL, certified reference material, Cerilliant®

D-062

21-脱氧皮质激素标准液 溶液, 100 μg/mL in methanol, ampule of 1 mL, certified reference material, Cerilliant®

D-076

21-氧氢化可的松-d8 (2,2,4,6,6,21,21,21-d8)标准液, 100 μg/mL in methanol, ampule of 1 mL, certified reference material, Cerilliant®

D-078

11-脱氧皮质醇-D5标准液 CRM, 100 μg/mL in methanol, ampule of 1 mL, certified reference material, Cerilliant®

D-085

地塞米松 溶液, 1.0 mg/mL in methanol, ampule of 1 mL, certified reference material, Cerilliant®

H-085

17α-羟孕酮标准液 溶液, 1.0 mg/mL in methanol, ampule of 1 mL, certified reference material, Cerilliant®

H-096

17α-羟基孕酮-D8(2,2,4,6,6,21,21-D8)标准液, 100 μg/mL in methanol, ampule of 1 mL, certified reference material, Cerilliant®

H-100

17α-羟孕酮-13C3标准液 溶液, 100 μg/mL in methanol, ampule of 1 mL, certified reference material, Cerilliant®

P-069

孕酮 溶液, 1.0 mg/mL in acetonitrile, ampule of 1 mL, certified reference material, Cerilliant®

P-070

孕酮-D9标准液 CRM 溶液, 100 μg/mL in acetonitrile, ampule of 1 mL, certified reference material, Cerilliant®

H-151

6alpha-Hydroxyhydrocortisone solution, 1 mg/mL in methanol, certified reference material, ampule of 1 mL, Cerilliant®

C-160

Cortisone-13C3 solution, 100 μg/mL in methanol, certified reference material, ampule of 1 mL, Cerilliant®

C-159

Corticosterone-13C3 solution, 10 μg/mL in methanol, certified reference material, ampule of 1 mL, Cerilliant®

P-123

泼尼松龙-13C3 溶液, 100 μg/mL in acetonitrile, certified reference material, ampule of 1 mL, Cerilliant®

P-124

Prednisone-13C3 solution, 100 μg/mL in acetonitrile, certified reference material, ampule of 1 mL, Cerilliant®

警示用语：

Danger

危险分类

Acute Tox. 3 Dermal - Acute Tox. 3 Inhalation - Acute Tox. 3 Oral - Flam. Liq. 2 - STOT SE 1

储存分类代码

3 - Flammable liquids

WGK

WGK 2

闪点(°F)

49.5 °F - closed cup

闪点(°C)

9.7 °C - closed cup

法规信息

危险化学品

分析证书(COA)

输入产品批号来搜索 分析证书(COA) 。批号可以在产品标签上"批“ （Lot或Batch）字后找到。

已有该产品？

为方便起见，与您过往购买产品相关的文件已保存在文档库中。

访问文档库

难以找到您所需的产品或批次号码？

在网站页面上，产品编号会附带包装尺寸/数量一起显示（例如：T1503-25G）。请确保 在“产品编号”字段中仅输入产品编号 (示例: T1503).

示例

T1503
货号
-
25G
包装规格/数量

其它示例：

705578-5MG-PW

PL860-CGA/SHF-1EA

MMYOMAG-74K-13

1000309185

输入内容 1.000309185)

遇到问题？欢迎随时联系我们技术服务 寻求帮助

批号可以在产品标签上"批“ （Lot或Batch）字后面找到。

Aldrich 产品

  • 如果您查询到的批号为 TO09019TO 等，请输入去除前两位字母的批号：09019TO。

  • 如果您查询到的批号含有填充代码（例如05427ES-021），请输入去除填充代码-021的批号：05427ES。

  • 如果您查询到的批号含有填充代码（例如 STBB0728K9），请输入去除填充代码K9的批号：STBB0728。

未找到您寻找的产品？

部分情况下，可能未在线提供COA。如果搜索不到COA，可在线索取。

索取COA

[Cortisone substitution in sepsis. Is less more?].
J Briegel
Der Anaesthesist, 52 Suppl 1, S24-S31 (2004-01-17)
I Uttner et al.
Der Nervenarzt, 77(6), 647-648 (2005-11-12)
Treatment with high-dose corticosteroids over 3-5 days reduces the duration and severity of relapses in patients with multiple sclerosis. Since the benefit of this treatment appears to be dose-dependent, application of ultrahigh steroid doses becomes important. On the other hand
M Malaguarnera et al.
Pharmacotherapy, 17(5), 998-1005 (1997-11-05)
Over the last 30 years many approaches have been adopted to treat chronic hepatitis. We conducted a meta-analysis to assess the efficacy of various types of treatments. We selected 4 studies of cortisone in chronic hepatitis B; 21 trials of
Stephen G Hillier
The Journal of endocrinology, 195(1), 1-6 (2007-10-04)
The year 1946 was not only the year that the Society for Endocrinology was founded, but also the year that Edward Kendall's compound E (cortisone) was first synthesised by Louis Sarett. By 1948, sufficient quantities of compound E were available
H Pirgă
Oftalmologia (Bucharest, Romania : 1990), 37(2), 154-156 (1993-03-01)
The cortisonical treatment has been more and more used in the last years, with an anti-inflammatory purpose, in ocular and general affections. The most severe ocular complications due to the prolonged treatment are the cortisonic glaucomas and the cortisonic cataract
查看所有相关文献

商品

Steroid Hormone Analysis in Serum using Supel™ Swift HLB DPX Tips

This application note describes an accurate and sensitive, Supel™ Swift HLB DPX Tips based analysis of a total of 9 steroids (cortisone, cortisol, 11-deoxycortisol, androstenedione, testosterone, dehydroepiandrosterone, 5α-dihydrotestosterone, 17α-hydroxyprogesterone, and progesterone) in blood serum samples using two different standards (UTAK and NIST).

我们的科学家团队拥有各种研究领域经验，包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.

联系技术服务部门